Literature DB >> 8318044

Fc gamma receptor activation of neutrophils in cryoglobulin-induced leukocytoclastic vasculitis.

M Hundt1, M Zielinska-Skowronek, R E Schmidt.   

Abstract

OBJECTIVE: The role of Fc gamma receptors (Fc gamma R) in type I cryoglobulinemia was investigated to characterize novel mechanisms of neutrophil activation in the pathogenesis of leukocytoclastic vasculitis.
METHODS: Neutrophils from healthy donors were incubated with purified monoclonal IgG1 kappa cryoglobulin complexes in vitro. Changes in surface antigen expression and mechanisms of intracellular hydrogen peroxide production and calcium release were measured by flow cytometry.
RESULTS: After incubation for 2 hours, surface expression of Fc gamma RI (CD64), CD66, and CD67 was up-regulated; Fc gamma RII (CDw32), Fc gamma RIII (CD16), and LAM-1 were down-regulated. Using solubilized and complexed cryoglobulins, it was demonstrated that complex formation is necessary to induce intracellular H2O2 production and calcium release from intracellular stores. Both H2O2 generation and calcium mobilization could be inhibited by pretreatment with F(ab')2 fragments of monoclonal antibodies (MAb) against Fc gamma RIII. In contrast, Fab fragments of anti-Fc gamma RII MAb failed to block these activations. Neither the cryoglobulin complex-induced production of H2O2 nor the increase in cytoplasmic calcium was affected by treatment with pertussis toxin, which suggests that pertussis toxin-sensitive G proteins are not involved in signal transduction.
CONCLUSION: These results indicate that Fc gamma RIII plays a major role in the pathogenesis of leukocytoclastic vasculitis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8318044     DOI: 10.1002/art.1780360715

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  2 in total

1.  The high-affinity Fc gamma RI on PMN: regulation of expression and signal transduction.

Authors:  F Hoffmeyer; K Witte; R E Schmidt
Journal:  Immunology       Date:  1997-12       Impact factor: 7.397

2.  Leukocytoclastic vasculitis and long-term remission in a patient with secondary AML and post-remission treatment with low-dose interleukin-2.

Authors:  M Engelhardt; J A Rump; U Hellerich; R Mertelsmann; A Lindemann
Journal:  Ann Hematol       Date:  1995-04       Impact factor: 3.673

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.